By Sachin Ravikumar & Anuron Kumar Mitra | Reuters |
Topics Wockhardt | Coronavirus Vaccine | UK
Pharma major Wockhardt will supply millions of doses of multiple Covid-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK announced on Monday.
Shares of the firm jumped 10 per cent after the news.
The firm has reserved fill-and-finish capacity — the final manufacturing step of putting vaccines into vials or syringes and packaging them — as part of the agreement, it said. This is the latest step by the UK to secure supplies and production of Covid-19 vaccines after.
This article is no longer available in our repository.
There could be multiple reasons for this.
You could try searching for this headline on the source website (bloomberg.com).